Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: A question of drug, timing or both?

Annals of Oncology

Volumn 27, Issue 3, 2016, Pages 371-372

  Dhermain, F ^a   Deutsch, E ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE INHIBITOR; CHECKPOINT KINASE INHIBITOR; IPILIMUMAB; NIVOLUMAB; PROGRAMMED DEATH 1 RECEPTOR; STEROID;

BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CELL DEATH; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EDITORIAL; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; INCIDENCE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION NECROSIS; STEREOTACTIC TREATMENT; TUMOR BLEEDING; TUMOR IMMUNITY; TUMOR VOLUME; RADIOSURGERY;

HUMANS; MELANOMA; RADIOSURGERY;

EID: 84959900334     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw001     Document Type: Editorial

References (11)

1. Ahmed KA, Stallworth DG, Kim Y et al. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol 2016; 27: 434-441.
2. Kohutek ZA, Yamada Y, Chan TA et al. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. J Neurooncol 2015; 125: 149-156.
3. Schadendorf D, Hodi FS, Robert C et al. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J Clin Oncol 2015; 33: 1889-1894.
4. Anker CJ, Ribas A, Grossmann AH et al. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol 2013; 31: e283-e287.
5. Sneed PK, Mendez J, Vemer-van den Hoek JG et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 2015; 123: 373-386.
6. Shaw E, Scott C, Souhami L et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291-298.
7. Gerosa M, Nicolato A, Foroni R et al. Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J Neurosurg 2002; 97: 515-524.
8. Liew DN, Kano H, Kondziolka D et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011; 114: 769-779.
9. Kiess AP, Wolchok JD, Barker CA et al. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys 2015; 92: 368-375.
10. Deutsch E, Dhermain F, Chargari C. Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drugradiotherapy combination? Ann Oncol 2014; 25: 2293-2294.
11. Vacchelli E, Vitale I, Tartour E et al. Trial Watch: anticancer radioimmunotherapy. Oncoimmunology 2013; 2: e25595.